Effects of the combinations propofol/alfentanil and midazolam/fentanyl on blood pressure and contact phase system during coronary surgery.
Perioperative haemodynamic changes leading to severe circulatory problems during open-heart surgery still represent dreaded complications. The aim of this study was to examine the relationship between the use of applied anaesthetic agents and alterations of the contact phase of the intrinsic blood-clotting system, as changes within the kallikrein-kinin system can lead to a fall in blood pressure. In a randomized study, parameters of the kallikrein-kinin system, coagulation and fibrinolysis were determined for 36 patients with aortocoronary bypass operations. The patients had been given either midazolam/fentanyl or propofol/alfentanil to maintain anaesthesia. Perioperative blood pressure values were registered at seven fixed points. The measured values of the factor XIIa-like activity and the kallikrein-like activity suggested a higher activation of the contact phase, when propofol/alfentanil was given. From the start of the extracorporeal circulation (ECC) to the end of the operation, the kallikrein-like activities in the propofol/alfentanil group were significantly higher than those of the midazolam/fentanyl group. Also, the results of the kallikrein inhibition capacity and the indicators of fibrinolysis (t-PA and D-dimers) indicate a stronger activation of the contact phase--at least at the beginning of recirculation--and as a result of it, a stronger fibrinolysis within the propofol/alfentanil group. In addition, the hypotensive side-effects differed significantly between the two groups. Patients receiving propofol/alfentanil needed the triple amount of antihypotonicum to maintain the mean arterial blood pressure above 75 mmHg. With the results of this study, a correlation between the application of propofol/alfentanil, contact phase activation, with activation of the kallikrein-kinin-bradykinin system and the observed hypotension, can be presumed.
Department of Thoracic and Cardiovascular Surgery, University of Tübingen, Germany.
H J
HJ
Schulze
H P
HP
Wendel
M
M
Kleinhans
S
S
Oehmichen
H
H
Guggenberger
W
W
Heller
H E
HE
Hoffmeister
D015760:Alfentanil / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects*; D006348:Cardiac Surgical Procedures; D001026:Coronary Artery Bypass; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D016234:Kallikrein-Kinin System / Q000187:drug effects; D008297:Male; D008874:Midazolam / Q000008:administration & dosage; D015742:Propofol / Q000008:administration & dosage
D018686:Anesthetics, Intravenous; D015760:Alfentanil; D008874:Midazolam; D005283:Fentanyl; D015742:Propofol